BackProtagenic Therapeutics Overview

Protagenic Therapeutics Long Term Debt

Track Protagenic Therapeutics's long-term debt ($0) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Long Term Debt
$0.00

Peer trimmed avg / median

Loading

Protagenic Therapeutics Long Term Debt History

Loading

Protagenic Therapeutics vs. peers: Long Term Debt Comparison

Loading

Protagenic Therapeutics Long Term Debt Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Protagenic Therapeutics (PTIX) FAQ

Protagenic Therapeutics (PTIX) currently reports a long-term debt of $0 as of June 2026. In the prior-year period, the figure was $0. Use the charts on this page to explore Protagenic Therapeutics's long-term debt history and peer comparisons.

Protagenic Therapeutics's long-term debt changed from $0 to $0 (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Protagenic Therapeutics reported $0 in long-term debt as of June 2026. In the prior-year period, the figure was $0. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current long-term debt of $0, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Protagenic Therapeutics, and consider following PTIX for alerts when major investors trade the stock.

Protagenic Therapeutics is classified in the Industrials sector. On long-term debt, it currently shows $0. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Industrials are usually more informative than comparing PTIX with unrelated industries.